C9ORF102 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.033000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.057800E-01
Normal-vs-Stage2
1.519580E-01
Normal-vs-Stage3
1.800850E-01
Normal-vs-Stage4
7.576200E-01
Stage1-vs-Stage2
4.483400E-01
Stage1-vs-Stage3
3.787800E-02
Stage1-vs-Stage4
2.528800E-01
Stage2-vs-Stage3
9.294000E-02
Stage2-vs-Stage4
2.066000E-02
Stage3-vs-Stage4
6.481700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.958030E-01
Normal-vs-AfricanAmerican
5.496200E-01
Normal-vs-Asian
1.850650E-01
Caucasian-vs-AfricanAmerican
5.731400E-01
Caucasian-vs-Asian
4.955000E-01
AfricanAmerican-vs-Asian
4.083600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.055780E-01
Normal-vs-Female
3.561600E-01
Male-vs-Female
1.384170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.802800E-01
Normal-vs-Age(41-60Yrs)
5.217000E-01
Normal-vs-Age(61-80Yrs)
1.070970E-01
Normal-vs-Age(81-100Yrs)
5.208200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.182400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.651000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.602200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.792300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.531590E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.070600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.670400E-02
Normal-vs-Daily Drinker
1.764220E-02
Normal-vs-Weekly Drinker
1.050030E-01
Normal-vs-Occasional Drinker
5.201800E-01
Normal-vs-Social Drinker
8.496600E-01
Non Drinker-vs-Daily Drinker
4.321400E-01
Non Drinker-vs-Weekly Drinker
8.941200E-01
Non Drinker-vs-Occasional Drinker
1.616150E-01
Non Drinker-vs-Social Drinker
1.006830E-01
Daily Drinker-vs-Weekly Drinker
4.034200E-01
Daily Drinker-vs-Occasional Drinker
5.931500E-02
Daily Drinker-vs-Social Drinker
4.989600E-02
Weekly Drinker-vs-Occasional Drinker
2.553800E-01
Weekly Drinker-vs-Social Drinker
1.285570E-01
Occasional Drinker-vs-Social Drinker
5.388600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.933170E-01
Normal-vs-Grade 2
1.200040E-01
Normal-vs-Grade 3
4.404100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.624000E-01
Grade 1-vs-Grade 3
8.123800E-01
Grade 1-vs-Grade 4
1.933170E-01
Grade 2-vs-Grade 3
5.634000E-01
Grade 2-vs-Grade 4
1.200040E-01
Grade 3-vs-Grade 4
4.404100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.654500E-02
Normal-vs-NonDiabetic
1.770440E-01
Diabetic-vs-NonDiabetic
8.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.005600E-01
Normal-vs-NoPancreatitis
1.975840E-01
Pancreatitis-vs-NoPancreatitis
8.436300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.309800E-01
Normal-vs-N1
1.690780E-01
N0-vs-N1
7.216600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.169200E-01
Normal-vs-TP53-NonMutant
5.369400E-01
TP53-Mutant-vs-TP53-NonMutant
3.762600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
